| 0037-6321 | URELLE ® Urinary Antiseptic | Viatris Specialty LLC |
| 0037-6321-90 | URELLE ® Urinary Antiseptic | Viatris Specialty LLC |
| 0076-0111 | Uribel ™ | Star Pharmaceuticals, LLC |
| 0076-0111-01 | Uribel ™ | Star Pharmaceuticals, LLC |
| 0076-0111-02 | Uribel ™ | Star Pharmaceuticals, LLC |
| 0076-0901 | Hyophen ™ | Star Pharmaceuticals, LLC |
| 0076-0901-01 | Hyophen ™ | Star Pharmaceuticals, LLC |
| 0076-0902 | Phosphasal ™ | Star Pharmaceuticals, LLC |
| 0076-0902-01 | Phosphasal ™ | Star Pharmaceuticals, LLC |
| 0076-0903 | Ustell™ | Star Pharmaceuticals LLC |
| 0076-0903-01 | Ustell™ | Star Pharmaceuticals LLC |
| 0143-9094 | These highlights do not include all the information needed to use METHYLENE BLUE INJECTION safely and effectively. See full prescribing information for METHYLENE BLUE INJECTION. METHYLENE BLUE Injection, USP for intravenous use Initial U.S. Approval: 2016 | Hikma Pharmaceuticals USA Inc. |
| 0143-9094-01 | These highlights do not include all the information needed to use METHYLENE BLUE INJECTION safely and effectively. See full prescribing information for METHYLENE BLUE INJECTION. METHYLENE BLUE Injection, USP for intravenous use Initial U.S. Approval: 2016 | Hikma Pharmaceuticals USA Inc. |
| 0143-9094-05 | These highlights do not include all the information needed to use METHYLENE BLUE INJECTION safely and effectively. See full prescribing information for METHYLENE BLUE INJECTION. METHYLENE BLUE Injection, USP for intravenous use Initial U.S. Approval: 2016 | Hikma Pharmaceuticals USA Inc. |
| 0178-0745 | Uribel Tabs | Mission Pharmacal Company |
| 0178-0745-01 | Uribel Tabs | Mission Pharmacal Company |
| 0485-0151 | UROGESIC-BLUE™ | EDWARDS PHARMACEUTICALS, INC. |
| 0485-0151 | UROGESIC-BLUE™ | EDWARDS PHARMACEUTICALS, INC. | AJENAT PHARMACEUTICALS LLC |
| 0485-0151 | UROGESIC-BLUE™ | EDWARDS PHARMACEUTICALS, INC. |
| 0485-0151-01 | UROGESIC-BLUE™ | EDWARDS PHARMACEUTICALS, INC. |
| 0485-0151-01 | UROGESIC-BLUE™ | EDWARDS PHARMACEUTICALS, INC. | AJENAT PHARMACEUTICALS LLC |
| 0485-0151-30 | UROGESIC-BLUE™ | EDWARDS PHARMACEUTICALS, INC. |
| 0517-0125 | These highlights do not include all the information needed to use (PROVAYBLUE) safely and effectively. See full prescribing information for (PROVAYBLUE). PROVAYBLUE ® (methylene blue) injection, USP for intravenous use Initial U.S. Approval: 2016 | American Regent, Inc. | Provepharm SAS | Cenexi | CENEXI HSC |
| 0517-0125-01 | These highlights do not include all the information needed to use (PROVAYBLUE) safely and effectively. See full prescribing information for (PROVAYBLUE). PROVAYBLUE ® (methylene blue) injection, USP for intravenous use Initial U.S. Approval: 2016 | American Regent, Inc. | Provepharm SAS | Cenexi | CENEXI HSC |
| 0517-0125-05 | These highlights do not include all the information needed to use (PROVAYBLUE) safely and effectively. See full prescribing information for (PROVAYBLUE). PROVAYBLUE ® (methylene blue) injection, USP for intravenous use Initial U.S. Approval: 2016 | American Regent, Inc. | Provepharm SAS | Cenexi | CENEXI HSC |
| 0517-0371 | These highlights do not include all the information needed to use (PROVAYBLUE) safely and effectively. See full prescribing information for (PROVAYBLUE). PROVAYBLUE ® (methylene blue) injection, USP for intravenous use Initial U.S. Approval: 2016 | American Regent, Inc. | Provepharm SAS | Cenexi | CENEXI HSC |
| 0517-0371-01 | These highlights do not include all the information needed to use (PROVAYBLUE) safely and effectively. See full prescribing information for (PROVAYBLUE). PROVAYBLUE ® (methylene blue) injection, USP for intravenous use Initial U.S. Approval: 2016 | American Regent, Inc. | Provepharm SAS | Cenexi | CENEXI HSC |
| 0517-0371-05 | These highlights do not include all the information needed to use (PROVAYBLUE) safely and effectively. See full prescribing information for (PROVAYBLUE). PROVAYBLUE ® (methylene blue) injection, USP for intravenous use Initial U.S. Approval: 2016 | American Regent, Inc. | Provepharm SAS | Cenexi | CENEXI HSC |
| 0517-0374 | These highlights do not include all the information needed to use (PROVAYBLUE) safely and effectively. See full prescribing information for (PROVAYBLUE). PROVAYBLUE ® (methylene blue) injection, USP for intravenous use Initial U.S. Approval: 2016 | American Regent, Inc. | Provepharm SAS | Cenexi | CENEXI HSC |
| 0517-0374-01 | These highlights do not include all the information needed to use (PROVAYBLUE) safely and effectively. See full prescribing information for (PROVAYBLUE). PROVAYBLUE ® (methylene blue) injection, USP for intravenous use Initial U.S. Approval: 2016 | American Regent, Inc. | Provepharm SAS | Cenexi | CENEXI HSC |
| 0517-0374-05 | These highlights do not include all the information needed to use (PROVAYBLUE) safely and effectively. See full prescribing information for (PROVAYBLUE). PROVAYBLUE ® (methylene blue) injection, USP for intravenous use Initial U.S. Approval: 2016 | American Regent, Inc. | Provepharm SAS | Cenexi | CENEXI HSC |
| 0517-0381 | These highlights do not include all the information needed to use (PROVAYBLUE) safely and effectively. See full prescribing information for (PROVAYBLUE). PROVAYBLUE ® (methylene blue) injection, USP for intravenous use Initial U.S. Approval: 2016 | American Regent, Inc. | Provepharm SAS | Cenexi | CENEXI HSC |
| 0517-0381-01 | These highlights do not include all the information needed to use (PROVAYBLUE) safely and effectively. See full prescribing information for (PROVAYBLUE). PROVAYBLUE ® (methylene blue) injection, USP for intravenous use Initial U.S. Approval: 2016 | American Regent, Inc. | Provepharm SAS | Cenexi | CENEXI HSC |
| 0517-0381-05 | These highlights do not include all the information needed to use (PROVAYBLUE) safely and effectively. See full prescribing information for (PROVAYBLUE). PROVAYBLUE ® (methylene blue) injection, USP for intravenous use Initial U.S. Approval: 2016 | American Regent, Inc. | Provepharm SAS | Cenexi | CENEXI HSC |
| 12539-144 | Uretron D/S | DORAL PHARMAMEDICS INC dba A.G. Marin Pharmaceuticals |
| 12539-144-01 | Uretron D/S | DORAL PHARMAMEDICS INC dba A.G. Marin Pharmaceuticals |
| 14789-119 | These highlights do not include all the information needed to use METHYLENE BLUE INJECTION safely and effectively. See full prescribing information for METHYLENE BLUE INJECTION. METHYLENE BLUE injection for intravenous use Initial U.S. Approval: 2016 | Nexus Pharmaceuticals, LLC | Nexus Pharmaceuticals LLC |
| 14789-119-05 | These highlights do not include all the information needed to use METHYLENE BLUE INJECTION safely and effectively. See full prescribing information for METHYLENE BLUE INJECTION. METHYLENE BLUE injection for intravenous use Initial U.S. Approval: 2016 | Nexus Pharmaceuticals, LLC | Nexus Pharmaceuticals LLC |
| 14789-119-07 | These highlights do not include all the information needed to use METHYLENE BLUE INJECTION safely and effectively. See full prescribing information for METHYLENE BLUE INJECTION. METHYLENE BLUE injection for intravenous use Initial U.S. Approval: 2016 | Nexus Pharmaceuticals, LLC | Nexus Pharmaceuticals LLC |
| 15243-344 | These highlights do not include all the information needed to use METHYLENE BLUE INJECTION safely and effectively. See full prescribing information for METHYLENE BLUE INJECTION. METHYLENE BLUE injection for intravenous use Initial U.S. Approval: 2016 | OLIC (Thailand) Limited |
| 15243-344-05 | These highlights do not include all the information needed to use METHYLENE BLUE INJECTION safely and effectively. See full prescribing information for METHYLENE BLUE INJECTION. METHYLENE BLUE injection for intravenous use Initial U.S. Approval: 2016 | OLIC (Thailand) Limited |
| 15243-344-07 | These highlights do not include all the information needed to use METHYLENE BLUE INJECTION safely and effectively. See full prescribing information for METHYLENE BLUE INJECTION. METHYLENE BLUE injection for intravenous use Initial U.S. Approval: 2016 | OLIC (Thailand) Limited |
| 15338-502 | UroAv-81 Tablets (Product contract packaged by Apace Packaging, LLC) | Apace Packaging, LLC | Apertus Pharmaceuticals, LLC |
| 15338-502-09 | UroAv-81 Tablets (Product contract packaged by Apace Packaging, LLC) | Apace Packaging, LLC | Apertus Pharmaceuticals, LLC |
| 15338-503 | UroAv-B Urinary Antiseptic (Product contract packaged by Apace Packaging, LLC) | Apace Packaging, LLC | Apertus Pharmaceuticals, LLC |
| 15338-503-10 | UroAv-B Urinary Antiseptic (Product contract packaged by Apace Packaging, LLC) | Apace Packaging, LLC | Apertus Pharmaceuticals, LLC |
| 17089-298 | GUNA-KIDNEY | Guna spa |
| 17089-298-18 | GUNA-KIDNEY | Guna spa |
| 28595-224 | URIMAR-T™ CAPS | Allegis Pharmaceuticals, LLC |
| 28595-224-60 | URIMAR-T™ CAPS | Allegis Pharmaceuticals, LLC |
| 28595-299 | MB CAPS | Allegis Pharmaceuticals, LLC |
| 28595-299-60 | MB CAPS | Allegis Pharmaceuticals, LLC |
| 43457-653 | Methylene Blue | KDG Impresa LLC, Aqion |
| 43457-653-25 | Methylene Blue | KDG Impresa LLC, Aqion |
| 54288-147 | Methylene Blue Injection, USP 1% | BPI LABS LLC |
| 54288-147-01 | Methylene Blue Injection, USP 1% | BPI LABS LLC |
| 54288-159 | Methylene Blue Injection, USP 1% | BPI LABS LLC |
| 54288-159-01 | Methylene Blue Injection, USP 1% | BPI LABS LLC |
| 54288-159-05 | Methylene Blue Injection, USP 1% | BPI LABS LLC |
| 54859-701 | Llorens Pharmaceutical International Division DailyMed label | Llorens Pharmaceutical International Division |
| 54859-701-04 | Llorens Pharmaceutical International Division DailyMed label | Llorens Pharmaceutical International Division |
| 54859-701-10 | Llorens Pharmaceutical International Division DailyMed label | Llorens Pharmaceutical International Division |
| 55999-053 | Stressguard™ | Seachem Laboratories Inc. |
| 55999-053-00 | Stressguard™ | Seachem Laboratories Inc. |
| 55999-053-01 | Stressguard™ | Seachem Laboratories Inc. |
| 55999-053-03 | Stressguard™ | Seachem Laboratories Inc. |
| 55999-053-06 | Stressguard™ | Seachem Laboratories Inc. |
| 55999-053-08 | Stressguard™ | Seachem Laboratories Inc. |
| 55999-053-09 | Stressguard™ | Seachem Laboratories Inc. |
| 55999-053-10 | Stressguard™ | Seachem Laboratories Inc. |
| 55999-053-52 | Stressguard™ | Seachem Laboratories Inc. |
| 55999-053-54 | Stressguard™ | Seachem Laboratories Inc. |
| 55999-053-58 | Stressguard™ | Seachem Laboratories Inc. |
| 55999-053-60 | Stressguard™ | Seachem Laboratories Inc. |
| 55999-053-62 | Stressguard™ | Seachem Laboratories Inc. |
| 55999-053-63 | Stressguard™ | Seachem Laboratories Inc. |
| 57955-0226 | CS Lung™ | King Bio Inc. |
| 57955-0226-2 | CS Lung™ | King Bio Inc. |
| 58657-454 | Me-NaPhos-MB-Hyo 1 Tablets | Method Pharmaceuticals |
| 58657-454-01 | Me-NaPhos-MB-Hyo 1 Tablets | Method Pharmaceuticals |
| 58657-456 | UroAv-B Urinary Antiseptic (Product contract packaged by Apace Packaging, LLC) | Apace Packaging, LLC | Apertus Pharmaceuticals, LLC |
| 58657-456 | URO-MP Capsules | Method Pharmaceuticals, LLC |
| 58657-456-01 | URO-MP Capsules | Method Pharmaceuticals, LLC |
| 58657-458 | UroAv-81 Tablets (Product contract packaged by Apace Packaging, LLC) | Apace Packaging, LLC | Apertus Pharmaceuticals, LLC |
| 68462-698 | These highlights do not include all the information needed to use METHYLENE BLUE INJECTION safely and effectively. See full prescribing information for METHYLENE BLUE INJECTION. METHYLENE BLUE injection, for intravenous use Initial U.S. Approval: 2016 | GLENMARK PHARMACEUTICALS INC., USA | Chengdu Shuode Pharmaceutical Co., Ltd |
| 68462-698-10 | These highlights do not include all the information needed to use METHYLENE BLUE INJECTION safely and effectively. See full prescribing information for METHYLENE BLUE INJECTION. METHYLENE BLUE injection, for intravenous use Initial U.S. Approval: 2016 | GLENMARK PHARMACEUTICALS INC., USA | Chengdu Shuode Pharmaceutical Co., Ltd |
| 68462-698-15 | These highlights do not include all the information needed to use METHYLENE BLUE INJECTION safely and effectively. See full prescribing information for METHYLENE BLUE INJECTION. METHYLENE BLUE injection, for intravenous use Initial U.S. Approval: 2016 | GLENMARK PHARMACEUTICALS INC., USA | Chengdu Shuode Pharmaceutical Co., Ltd |
| 70121-2715 | These highlights do not include all the information needed to use METHYLENE BLUE INJECTION safely and effectively. See full prescribing information for METHYLENE BLUE INJECTION. METHYLENE BLUE INJECTION, USP for intravenous use Initial U.S. Approval: 2016 | Amneal Pharmaceuticals LLC | STERISCIENCE SP Z O O |
| 70121-2715-2 | These highlights do not include all the information needed to use METHYLENE BLUE INJECTION safely and effectively. See full prescribing information for METHYLENE BLUE INJECTION. METHYLENE BLUE INJECTION, USP for intravenous use Initial U.S. Approval: 2016 | Amneal Pharmaceuticals LLC | STERISCIENCE SP Z O O |
| 70121-2715-3 | These highlights do not include all the information needed to use METHYLENE BLUE INJECTION safely and effectively. See full prescribing information for METHYLENE BLUE INJECTION. METHYLENE BLUE INJECTION, USP for intravenous use Initial U.S. Approval: 2016 | Amneal Pharmaceuticals LLC | STERISCIENCE SP Z O O |
| 70121-2716 | These highlights do not include all the information needed to use METHYLENE BLUE INJECTION safely and effectively. See full prescribing information for METHYLENE BLUE INJECTION. METHYLENE BLUE INJECTION, USP for intravenous use Initial U.S. Approval: 2016 | Amneal Pharmaceuticals LLC | STERISCIENCE SP Z O O |
| 70121-2716-2 | These highlights do not include all the information needed to use METHYLENE BLUE INJECTION safely and effectively. See full prescribing information for METHYLENE BLUE INJECTION. METHYLENE BLUE INJECTION, USP for intravenous use Initial U.S. Approval: 2016 | Amneal Pharmaceuticals LLC | STERISCIENCE SP Z O O |
| 70700-328 | These highlights do not include all the information needed to use METHYLENE BLUE INJECTION safely and effectively. See full prescribing information for METHYLENE BLUE INJECTION. METHYLENE BLUE injection, USP for intravenous use Initial U.S. Approval: 2016 | XIROMED, LLC | XIROMED PHARMA ESPAÑA, S.L |
| 70700-328-22 | These highlights do not include all the information needed to use METHYLENE BLUE INJECTION safely and effectively. See full prescribing information for METHYLENE BLUE INJECTION. METHYLENE BLUE injection, USP for intravenous use Initial U.S. Approval: 2016 | XIROMED, LLC | XIROMED PHARMA ESPAÑA, S.L |
| 70700-328-24 | These highlights do not include all the information needed to use METHYLENE BLUE INJECTION safely and effectively. See full prescribing information for METHYLENE BLUE INJECTION. METHYLENE BLUE injection, USP for intravenous use Initial U.S. Approval: 2016 | XIROMED, LLC | XIROMED PHARMA ESPAÑA, S.L |
| 70710-1837 | These highlights do not include all the information needed to use METHYLENE BLUE INJECTION safely and effectively. See full prescribing information for METHYLENE BLUE INJECTION. METHYLENE BLUE Injection, for intravenous use Initial U.S. Approval: 2016 | Zydus Pharmaceuticals USA Inc. | Zydus Lifesciences Global FZE | Zydus Lifesciences Limited |
| 70710-1837-1 | These highlights do not include all the information needed to use METHYLENE BLUE INJECTION safely and effectively. See full prescribing information for METHYLENE BLUE INJECTION. METHYLENE BLUE Injection, for intravenous use Initial U.S. Approval: 2016 | Zydus Pharmaceuticals USA Inc. | Zydus Lifesciences Global FZE | Zydus Lifesciences Limited |
| 70710-1837-5 | These highlights do not include all the information needed to use METHYLENE BLUE INJECTION safely and effectively. See full prescribing information for METHYLENE BLUE INJECTION. METHYLENE BLUE Injection, for intravenous use Initial U.S. Approval: 2016 | Zydus Pharmaceuticals USA Inc. | Zydus Lifesciences Global FZE | Zydus Lifesciences Limited |
| 70710-1838 | These highlights do not include all the information needed to use METHYLENE BLUE INJECTION safely and effectively. See full prescribing information for METHYLENE BLUE INJECTION. METHYLENE BLUE Injection, for intravenous use Initial U.S. Approval: 2016 | Zydus Pharmaceuticals USA Inc. | Zydus Lifesciences Global FZE | Zydus Lifesciences Limited |
| 70710-1838-1 | These highlights do not include all the information needed to use METHYLENE BLUE INJECTION safely and effectively. See full prescribing information for METHYLENE BLUE INJECTION. METHYLENE BLUE Injection, for intravenous use Initial U.S. Approval: 2016 | Zydus Pharmaceuticals USA Inc. | Zydus Lifesciences Global FZE | Zydus Lifesciences Limited |
| 70710-1838-5 | These highlights do not include all the information needed to use METHYLENE BLUE INJECTION safely and effectively. See full prescribing information for METHYLENE BLUE INJECTION. METHYLENE BLUE Injection, for intravenous use Initial U.S. Approval: 2016 | Zydus Pharmaceuticals USA Inc. | Zydus Lifesciences Global FZE | Zydus Lifesciences Limited |
| 70710-2083 | These highlights do not include all the information needed to use METHYLENE BLUE INJECTION safely and effectively. See full prescribing information for METHYLENE BLUE INJECTION. METHYLENE BLUE Injection, for intravenous use Initial U.S. Approval: 2016 | Zydus Pharmaceuticals USA Inc. | Zydus Lifesciences Global FZE | Zydus Lifesciences Limited |
| 70710-2083-1 | These highlights do not include all the information needed to use METHYLENE BLUE INJECTION safely and effectively. See full prescribing information for METHYLENE BLUE INJECTION. METHYLENE BLUE Injection, for intravenous use Initial U.S. Approval: 2016 | Zydus Pharmaceuticals USA Inc. | Zydus Lifesciences Global FZE | Zydus Lifesciences Limited |
| 70710-2083-5 | These highlights do not include all the information needed to use METHYLENE BLUE INJECTION safely and effectively. See full prescribing information for METHYLENE BLUE INJECTION. METHYLENE BLUE Injection, for intravenous use Initial U.S. Approval: 2016 | Zydus Pharmaceuticals USA Inc. | Zydus Lifesciences Global FZE | Zydus Lifesciences Limited |
| 70771-1767 | Methylene Blue Injection, USP | Zydus Lifesciences Limited |
| 70771-1767-1 | Methylene Blue Injection, USP | Zydus Lifesciences Limited |
| 70771-1767-5 | Methylene Blue Injection, USP | Zydus Lifesciences Limited |
| 70771-1768 | Methylene Blue Injection, USP | Zydus Lifesciences Limited |
| 70771-1768-1 | Methylene Blue Injection, USP | Zydus Lifesciences Limited |
| 70771-1768-5 | Methylene Blue Injection, USP | Zydus Lifesciences Limited |
| 70771-1963 | Methylene Blue Injection, USP | Zydus Lifesciences Limited |
| 70771-1963-1 | Methylene Blue Injection, USP | Zydus Lifesciences Limited |
| 70771-1963-5 | Methylene Blue Injection, USP | Zydus Lifesciences Limited |
| 71186-000 | VILEVEV MB Tablets | Vilvet Pharmaceuticals Inc |
| 71186-000-24 | VILEVEV MB Tablets | Vilvet Pharmaceuticals Inc |
| 71186-002 | VILAMIT MB Capsules | Vilvet Pharmaceuticals Inc |
| 71186-002-35 | VILAMIT MB Capsules | Vilvet Pharmaceuticals Inc |
| 71288-811 | These highlights do not include all the information needed to use METHYLENE BLUE INJECTION safely and effectively. See full prescribing information for METHYLENE BLUE INJECTION. METHYLENE BLUE injection, for intravenous use Initial U.S. Approval: 2016 | Meitheal Pharmaceuticals Inc. | Nanjing King-Friend Biochemical Pharmaceutical Co., Ltd. |
| 71288-811-10 | These highlights do not include all the information needed to use METHYLENE BLUE INJECTION safely and effectively. See full prescribing information for METHYLENE BLUE INJECTION. METHYLENE BLUE injection, for intravenous use Initial U.S. Approval: 2016 | Meitheal Pharmaceuticals Inc. | Nanjing King-Friend Biochemical Pharmaceutical Co., Ltd. |
| 71288-811-11 | These highlights do not include all the information needed to use METHYLENE BLUE INJECTION safely and effectively. See full prescribing information for METHYLENE BLUE INJECTION. METHYLENE BLUE injection, for intravenous use Initial U.S. Approval: 2016 | Meitheal Pharmaceuticals Inc. | Nanjing King-Friend Biochemical Pharmaceutical Co., Ltd. |